Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The search for the ideal SERM.

Banu Arun1, Marietta Anthony, Barbara Dunn

  • 1Department of Breast Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA. barun@mdanderson.org

Expert Opinion on Pharmacotherapy
|May 31, 2002
PubMed
Summary

Selective oestrogen receptor modulators (SERMs) offer targeted effects, acting as agonists or antagonists in specific tissues. Research aims to develop ideal SERMs with improved benefits for cancer, bone health, and cognition, while minimizing risks like endometrial cancer.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE.

Journal of the National Cancer Institute·2026
Same author

Lifestyle Program for Breast Cancer Improves Body Composition, Fitness, and Patient-Reported Outcomes: A Randomized Clinical Trial.

Cancers·2026
Same author

Erratum: Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

JCO precision oncology·2026
Same author

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.

Breast cancer research : BCR·2026
Same author

Ionizing Radiation Enhances Prognostically Significant Cellular Immunity Programs in the Brain Metastasis Microenvironment.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Same author

Using Experimental Evolution to Correct Mother-Daughter Separation Defects in Brewing Yeast.

microPublication biology·2026

Area of Science:

  • Endocrinology and Pharmacology
  • Molecular Biology
  • Oncology

Background:

  • Selective oestrogen receptor modulators (SERMs) interact with oestrogen receptors, exhibiting tissue-specific agonist or antagonist activity.
  • SERMs offer potential for improved risk:benefit profiles compared to traditional hormone replacement therapy.
  • Current SERMs like tamoxifen have demonstrated efficacy but also associated risks, such as endometrial cancer.

Purpose of the Study:

  • To review the current landscape of SERM development and their therapeutic applications.
  • To highlight the potential of novel SERMs in addressing unmet needs in women's health.
  • To outline the ongoing research efforts towards developing an ideal SERM with enhanced efficacy and safety.

Main Methods:

  • Literature review of existing studies on SERMs, oestrogen, and hormone replacement therapy.

Related Experiment Videos

  • Analysis of clinical data regarding the efficacy and toxicity profiles of various SERMs.
  • Exploration of emerging research on molecular mechanisms and therapeutic targets for SERMs.

    • Main Results:

    • Tamoxifen acts as an oestrogen antagonist in breast tissue, aiding cancer treatment, but is an agonist in the endometrium, increasing cancer risk.
    • Oestrogen and raloxifene show efficacy in preventing osteoporosis, while oestrogen has not demonstrated secondary prevention for coronary heart disease.
    • SERMs can induce menopausal symptoms like hot flushes, contrasting with oestrogen's use in symptom management.

    Conclusions:

    • The development of ideal SERMs is crucial for simultaneously addressing multiple health concerns including cancer, cardiovascular disease, osteoporosis, and menopausal symptoms.
    • Future SERMs aim to maximize therapeutic benefits while significantly improving safety profiles, particularly concerning endometrial cancer and thromboembolic events.
    • Targeted modulation of oestrogen receptor pathways holds promise for personalized medicine in women's health.